A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma

  1. Anderson, P.M.
  2. Bielack, S.S.
  3. Gorlick, R.G.
  4. Skubitz, K.
  5. Daw, N.C.
  6. Herzog, C.E.
  7. Monge, O.R.
  8. Lassaletta, A.
  9. Boldrini, E.
  10. Pápai, Z.
  11. Rubino, J.
  12. Pathiraja, K.
  13. Hille, D.A.
  14. Ayers, M.
  15. Yao, S.-L.
  16. Nebozhyn, M.
  17. Lu, B.
  18. Mauro, D.
Aldizkaria:
Pediatric Blood and Cancer

ISSN: 1545-5017,  1545-5009

Argitalpen urtea: 2016

Alea: 63

Zenbakia: 10

Orrialdeak: 1761-1770

Mota: Artikulua

DOI: 10.1002/PBC.26087 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus